| Předmět: |
|
| Zdroj: |
Cancer Weekly; 11/19/2024, p665-665, 1p |
| Abstrakt: |
Researchers at Taipei Medical University have conducted a study on pancreatic cancer, focusing on the role of Dicer phosphorylation in gemcitabine resistance. The study found that phosphorylation at specific sites on Dicer promotes resistance to gemcitabine by reprogramming glutamine metabolism, leading to increased drug resistance. These findings provide insights into potential therapeutic strategies for overcoming gemcitabine resistance in pancreatic cancer. The study was funded by the Ministry of Education in Taiwan and was published in the International Journal of Molecular Sciences. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
